Recombinant leptin therapy is very effective in patients with generalized lipodystrophy and to a lesser extent in other forms of partial lipodystrophy, but leptin levels in most patients with FPLD1 are well above current thresholds (4 to 10 μg/L) for leptin therapy (3). The gene discussed is LEP; the disease is partial lipodystrophy.